Attenuation of JAK2 by miR-204 in HNSCC inhibited the JAK2/JAK3 pathway preventing tumor angiogenesis and increased sensitivity to cetuximab suggesting a tumor suppressive activity (Wu Y. et al., 2018). This evidence concerns the gene JAK2 and head and neck squamous cell carcinoma.